These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22955913)

  • 1. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion.
    Tripodo C; Sangaletti S; Guarnotta C; Piccaluga PP; Cacciatore M; Giuliano M; Franco G; Chiodoni C; Sciandra M; Miotti S; Calvaruso G; Carè A; Florena AM; Scotlandi K; Orazi A; Pileri SA; Colombo MP
    Blood; 2012 Oct; 120(17):3541-54. PubMed ID: 22955913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of the bone marrow niche in patients with myeloproliferative neoplasms: ActivinA secretion by mesenchymal stromal cells correlates with the degree of marrow fibrosis.
    Rambaldi B; Diral E; Donsante S; Di Marzo N; Mottadelli F; Cardinale L; Dander E; Isimbaldi G; Pioltelli P; Biondi A; Riminucci M; D'Amico G; Elli EM; Pievani A; Serafini M
    Ann Hematol; 2021 Jan; 100(1):105-116. PubMed ID: 33089365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib interferes with adhesion of B cell precursor acute lymphoblastic leukemia cells through SPARC up-regulation in human bone marrow mesenchymal stromal/stem cells.
    Iwasa M; Miura Y; Fujishiro A; Fujii S; Sugino N; Yoshioka S; Yokota A; Hishita T; Hirai H; Andoh A; Ichinohe T; Maekawa T
    Int J Hematol; 2017 May; 105(5):587-597. PubMed ID: 28044259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.
    Sangaletti S; Tripodo C; Portararo P; Dugo M; Vitali C; Botti L; Guarnotta C; Cappetti B; Gulino A; Torselli I; Casalini P; Chiodoni C; Colombo MP
    Oncoimmunology; 2014; 3():e28989. PubMed ID: 25083326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPARC deficiency affects bone marrow stromal function, resulting in impaired B lymphopoiesis.
    Luo Z; Zhou Y; Luo P; Zhao Q; Xiao N; Yu Y; Yan Q; Lu G; Cheng L
    J Leukoc Biol; 2014 Jul; 96(1):73-82. PubMed ID: 24598056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.
    Schepers K; Pietras EM; Reynaud D; Flach J; Binnewies M; Garg T; Wagers AJ; Hsiao EC; Passegué E
    Cell Stem Cell; 2013 Sep; 13(3):285-99. PubMed ID: 23850243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCN2/CTGF expression does not correlate with fibrosis in myeloproliferative neoplasms, consistent with noncanonical TGF-β signaling driving myelofibrosis.
    Leguit RJ; Broekhuizen R; de Witte M; Raymakers RAP; Goldschmeding R
    Virchows Arch; 2024 May; 484(5):837-845. PubMed ID: 38602559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
    Ozono Y; Shide K; Kameda T; Kamiunten A; Tahira Y; Sekine M; Akizuki K; Nakamura K; Iwakiri H; Sueta M; Hidaka T; Kubuki Y; Yamamoto S; Hasuike S; Sawaguchi A; Nagata K; Shimoda K
    Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
    Sangaletti S; Tripodo C; Santangelo A; Castioni N; Portararo P; Gulino A; Botti L; Parenza M; Cappetti B; Orlandi R; Tagliabue E; Chiodoni C; Colombo MP
    Cell Rep; 2016 Sep; 17(1):233-248. PubMed ID: 27681434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells in myeloproliferative disorders - focus on primary myelofibrosis.
    Selicean SE; Tomuleasa C; Grewal R; Almeida-Porada G; Berindan-Neagoe I
    Leuk Lymphoma; 2019 Apr; 60(4):876-885. PubMed ID: 30277128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells induce tumor stroma formation and epithelial‑mesenchymal transition through SPARC expression in colorectal cancer.
    Naito T; Yuge R; Kitadai Y; Takigawa H; Higashi Y; Kuwai T; Kuraoka K; Tanaka S; Chayama K
    Oncol Rep; 2021 Jun; 45(6):. PubMed ID: 33907853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload.
    Riley HJ; Kelly RR; Van Laer AO; Neff LS; Dasgupta S; Baicu CF; McDonald LT; LaRue AC; Zile MR; Bradshaw AD
    Am J Physiol Heart Circ Physiol; 2021 Feb; 320(2):H604-H612. PubMed ID: 33306449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding deregulated cellular and molecular dynamics in the haematopoietic stem cell niche to develop novel therapeutics for bone marrow fibrosis.
    Gleitz HF; Kramann R; Schneider RK
    J Pathol; 2018 Jun; 245(2):138-146. PubMed ID: 29570794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
    McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
    Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of myelofibrosis with myeloid metaplasia.
    Tefferi A
    J Clin Oncol; 2005 Nov; 23(33):8520-30. PubMed ID: 16293880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis.
    Tripodo C; Di Bernardo A; Ternullo MP; Guarnotta C; Porcasi R; Ingrao S; Gianelli U; Boveri E; Iannitto E; Franco G; Florena AM
    Haematologica; 2009 Jan; 94(1):127-30. PubMed ID: 19029148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis.
    Martinaud C; Desterke C; Konopacki J; Vannucchi AM; Pieri L; Guglielmelli P; Dupriez B; Ianotto JC; Boutin L; Lataillade JJ; Le Bousse-Kerdilès MC
    Genom Data; 2015 Sep; 5():1-2. PubMed ID: 26484208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte, rather than tumor-produced SPARC, determines stroma and collagen type IV deposition in mammary carcinoma.
    Sangaletti S; Stoppacciaro A; Guiducci C; Torrisi MR; Colombo MP
    J Exp Med; 2003 Nov; 198(10):1475-85. PubMed ID: 14610043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin-receptor-expressing bone marrow stromal cells are myofibroblasts in primary myelofibrosis.
    Decker M; Martinez-Morentin L; Wang G; Lee Y; Liu Q; Leslie J; Ding L
    Nat Cell Biol; 2017 Jun; 19(6):677-688. PubMed ID: 28481328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
    Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
    J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.